Glutathione and neurodegenerative diseases: immunopharmacological implications
Cardiovascular risk reduction alongside weight loss: Semaglutide
Acting as a Gatekeeper Silymarin is thought to bind to the outside of liver cells, acting like a protective barrier
Should I worry about MIC B12 potency loss if my fridge is warmer than usual
10.1073/pnas.58.4.1711 Proc
The Company has 8,396,600 warrants outstanding from prior financings EMCs Position in the Company Emerging Markets Consulting participated directly in this financing by investing: CAD $671,356 Purchasing: 1,342,712 shares at CAD $0.50 per share, representing approximately 33.6% of the CAD $2,000,000 offering (Note: $671,356 of a $2,000,000 round is 33.6%.) In addition, we separately acquired: 1,000,000 additional shares through a private transaction EMCs total holding of 2,342,712 shares represents approximately 4.47% of the 52,431,207 common shares outstanding